Company Overview and News
It’s important to differentiate the concept of enterprise free cash flow valuation and the idea of capital-market dependence.
FB APLP APA SNSR AND LIT XOM BFIT GXG SIL KRMA GXF ENB CHII SEP ACTX CHIE GOEX KMI FINX CHIX MMP KMR CVB SRET BOTZ CATH KML GURX GURI MORN ALUM MILN CJHIQ URA ENB ETP LNGR COPX QQQC GURU KMRFZ FANG
After enduring a mostly choppy trend in the past few months, investors may consider adding Apache Corporation (NYSE:APA) stock to their portfolio for the rest of the year. Specifically, there are three bullish plays in APA stock that I want to share with you, as each play could lead to impressive profits.
APA XOM PXD DVN
Your elementary science teacher probably taught you that oil and water don't mix, but when it comes to oil production, water plays an important role. In fact, water is both a necessity and a potential headache for oil and natural gas producers. Water is needed for hydraulic fracturing of wells, which involves pumping water, chemicals and sand into a well to open fractures to encourage production of hydrocarbons.
NGL AM NBLX APA ALDW CTLR CLR ALJ AR
2018-09-18 247wallst - 6
Stocks were indicated to open higher on Tuesday. U.S. equity indexes remain very close to their all-time highs, while most international markets are not close to their highs. One issue that has to be considered is that investors have seen less upside from buying on market pullbacks than in prior years. Investors also need to consider how they want to have their investments positioned for the rest of 2018.
APA GFI.WI AMD WMT ISCA CL BKU MS RIG GFIOF ORCL MRVL FDX AKCA MU URI TRI SBUX GFI ESRX
2018-09-13 zacks - 1
Following the release of EIA crude inventory numbers, worries about tightening global supplies and uncertainty over the potential impact of Hurricane Florence, oil prices settled at their highest since July 20 on Wednesday. West Texas Intermediate crude for October delivery gained $1.12, or 1.6%, to end the day at $70.37 a barrel in electronic trading.
DO APA DNR CXO MGY
The price of oil has gotten a renewed bid of late, and while I don’t expect this to be a straight shot to the moon from here, the bid looks to remain firm enough for higher prices in coming weeks/months. Not surprisingly, as a result shares of energy companies such as independent energy company Apache (NYSE:APA) are also now waking up. APA stock has popped more than 8% over the past four trading days and, all else being equal, looks to have plenty more upside left.
Pipeline constraints in the prolific Permian play have opened a window of opportunity for the midstream companies to build new projects or expand the existing ones. In this regard, major pipeline operators Energy Transfer Partners LP (ETP - Free Report) and Magellan Midstream Partners, LP (MMP - Free Report) have teamed up with Delek U.S. Holdings, Inc. (DK - Free Report) and midstream arm of Marathon Petroleum Corporation, MPLX LP (MPLX - Free Report) to construct a new multi-billion-dollar pipeline project.
MPLX APA NBL MPC ETP ALLY KMI MMP KMR PAA CVB KMRFZ
Kinder Morgan, Inc. (KMI - Free Report) recently announced that the company has reached a final investment decision (FID) on its $2-billion Permian Highway Pipeline (PHP) Project, through its subsidiary Kinder Morgan Texas Pipeline LLC (“KMTP”). Private firm Blackstone Energy Partners’ portfolio company, EagleClaw Midstream Ventures is a partner in the PHP project, which so far secured enough shipping commitments.
WFCNP KAAC APA XOM XTO KMI KMR CVB WFC MDR KHC KMRFZ MCDFF
2018-09-04 zacks - 1
For the longest time, Permian Basin has been the golden shale area of the United States. Crude output from the Permian has been on fire with the United States becoming the world’s numero uno oil producing country in 2017. While production in the Permian is soaring, its takeaway capacity in the region is not increasing to that proportion. This mismatch presents a massive opportunity to midstream companies as well as the refining players.
APA NBL XOM CXO PE VLO MPC EOG TSNU ETP DK RSPP CVX HFC EGN PAA OXY TSN FANG
HOUSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Apache Corporation (NYSE, Nasdaq: APA) today announced Emily McClung has been named vice president, Community Partnerships and Employee Engagement, effective Sept. 1, 2018.
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to APA / Apache Corp. on message board site Silicon Investor.
as of ET